Teladoc Health, Inc. (TDOC) Form 8-K — Oct 28, 2026

$TDOCForm 8-KItems 2.02, 9.01Filed Oct 28, 2026, 4:04 PM ET0001477449-26-000050Original filing

Teladoc Health reported Q3 2026 revenue of $605.1 million, down 3% year-over-year, with a net loss of $26.9 million ($0.15 per share) and adjusted EBITDA of $79.4 million, up 14%.

Key figures

Revenue: 605100000
Guidance: FY2026: revenue $2,395-$2,441M, adjusted EBITDA $277-$303M, net loss per share ($0.95)-($0.75), FCF $135-$165M; Q4 2026: revenue $569-$615M, adjusted EBITDA $74-$100M, net loss per share ($0.23)-($0.03).
Total Assets: 2775000000
Free cash flow q3: $75.9M
Adjusted ebitda q3: $79.4M (+14% YoY)
Betterhelp revenue q3: $206.6M (-13% YoY)
Betterhelp paying users: 0.336M (-12% YoY)
Betterhelp ebitda margin: 2.2%
Convertible notes current: $997.6M
Integrated care revenue q3: $398.5M (+2% YoY)
Us integrated care members: 100.1M (-2% YoY)
Integrated care ebitda margin: 18.8%

AI analysis

Red flags4 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $40.67/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.